Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Altimmune Inc. (ALT)

12.3   -0.62 (-4.8%) 09-29 08:42
Open: 13.13 Pre. Close: 12.92
High: 13.13 Low: 12
Volume: 1,217,514 Market Cap: 405M
Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. The company is headquartered in Gaithersburg, Maryland and currently employs 27 full-time employees. The firm is focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease. The Company’s product candidates include ALT-801, HepTcell, ALT-702, NasoVAX and NasoShield. HepTcell is a synthetic peptide immunotherapeutic candidate designed to break immune tolerance in chronic Hepatitis B infection. ALT-702, a TLR7/8 agonist conjugate, is a tumor immunostimulant product candidate that has the potential to safely elicit or improve immune responses in a variety of cancer indications. NasoVAX, its influenza vaccine candidate that stimulate multiple arms of the immune system and offers the potential to stop the infection and the spread of flu, while being easier to administer through an intranasal spray. NasoShield is an intranasal anthrax vaccine candidate that is designed to provide more rapid and stable protection than the only approved anthrax vaccine.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 13.147 - 13.211 13.211 - 13.274
Low: 11.824 - 11.899 11.899 - 11.973
Close: 12.158 - 12.28 12.28 - 12.399

Technical analysis

as of: 2020-09-28 4:29:43 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.40     One year: 27.80
Support: Support1: 11.70    Support2: 9.73
Resistance: Resistance1: 19.18    Resistance2: 23.80
Pivot: 12.97
Moving Average: MA(5): 12.83     MA(20): 13.35
MA(100): 15.20     MA(250): 7.43
MACD: MACD(12,26): -1.87     Signal(9): -2.11
Stochastic oscillator: %K(14,3): 18.24     %D(3): 21.43
RSI: RSI(14): 37.13
52-week: High: 35.10  Low: 1.51  Change(%): 547.4
Average Vol(K): 3-Month: 395446  10-Days: 177956

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ALT has closed above bottom band by 28.8%. Bollinger Bands are 67.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALT's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 29 Sep 2020
Check this Altimmune, Inc. (NASDAQ:ALT) Analysis Before You Invest - Stocks Register

Mon, 28 Sep 2020
The Chart for Altimmune Inc. (ALT) Is Flashing Mixed Signals - The News Heater

Mon, 28 Sep 2020
Altimmune Inc. (ALT) can’t be written off after posting last 3-months Average volume of 3.99M - The InvestChronicle

Mon, 28 Sep 2020
Shares of Altimmune, Inc. (NASDAQ:ALT) lost -40.1% in a month. - Marketing Sentinel

Fri, 25 Sep 2020
Does Altimmune Inc (ALT) Have What it Takes to be in Your Portfolio? - InvestorsObserver

Thu, 24 Sep 2020
How Does Altimmune Inc (ALT) Stock Rank on Wall Street? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 33
Shares Float (M) 24
% Held by Insiders 17.11
% Held by Institutions 8.38
Shares Short (K) 1,020
Shares Short P. Month (K) 717

Stock Financials

EPS -2.270
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.030
Profit Margin
Operating Margin -625.65
Return on Assets (ttm) -19.8
Return on Equity (ttm) -52.6
Qtrly Rev. Growth -55.6
Gross Profit (p.s.) -0.343
Sales Per Share 0.126
EBITDA (p.s.) -0.781
Qtrly Earnings Growth
Operating Cash Flow (M) -16
Levered Free Cash Flow (M) -17

Stock Valuations

PE Ratio -5.42
PEG Ratio
Price to Book value 4.06
Price to Sales 97.54
Price to Cash Flow -25.38

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date 2017-02-02
Ex-Dividend Date 2017-01-19
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.